The aim of the present study was to investigate the influence of Cs + on cultured human cells. We find that HeLa cell growth is suppressed by the addition of 10 mM CsCl into the culture media. In the Cs + -treated cells, the intracellular Cs + and K + concentrations are increased and decreased, respectively. This leads to a decrease in activity of the glycolytic enzyme pyruvate kinase, which uses K + as a cofactor. Cs + -treated cells show an intracellular pH shift towards alkalization. Based on these results, CsCl presumably suppresses HeLa cell proliferation by inducing an intracellular cation imbalance that affects cell metabolism. Our findings may have implications for the use of Cs + in cancer therapy.
The aim of the present study was to investigate the influence of Cs + on cultured human cells. We find that HeLa cell growth is suppressed by the addition of 10 mM CsCl into the culture media. In the Cs + -treated cells, the intracellular Cs + and K + concentrations are increased and decreased, respectively. This leads to a decrease in activity of the glycolytic enzyme pyruvate kinase, which uses K + as a cofactor. Cs + -treated cells show an intracellular pH shift towards alkalization. Based on these results, CsCl presumably suppresses HeLa cell proliferation by inducing an intracellular cation imbalance that affects cell metabolism. Our findings may have implications for the use of Cs + in cancer therapy.
Keywords: cell cycle; cesium; proliferation Cesium (Cs) is an alkali metal. Cs + has no known beneficial function in humans; however, it induces toxicity at high concentrations [1] . Although physiological Cs + uptake and responses in humans have not been studied well, several clinical studies reported Cs + administration to humans [2] , particularly in cancer therapy. Upon intravenous administration, Cs + accumulates in the human brain, liver, and kidneys. The half-life of Cs + in a human male adult ranges from 50 to 150 days [3] [4] [5] . In terms of its biological effects, very interesting attempts to use Cs as a cancer therapy have been reported. For instance, oral intake of CsCl has been used an alternative therapy for treating cancer. In these tests, 2-g doses of CsCl were administered three times per day after each meal with additional vitamins. Consequently, relief of cancer-associated pain and a rapid shrinkage of the tumor masses were reported [6, 7] . Neulieb orally treated himself with CsCl for 36 consecutive days and reported the effects [1] . No discomfort or debility of any kind was observed during the period, but symptoms of nausea and diarrhea were observed. Furthermore, in some cases, Cs intake caused polymorphic ventricular tachycardia, including torsades des pointes, and long QT syndrome [8, 9] . A few cases of confirmed tumor regression have been reported; however, these cases were not theoretically or experimentally validated. Currently, there is insufficient information about the acute and chronic toxicity of Cs + [10] . We must clarify the biological effects of Cs on cells to use Cs in clinical applications. Here, we investigated the influence of Cs + on cultured human cells, and evaluated cell proliferation, viability, and Cs incorporation in the cells. We also examined the possible mechanism for the cellular effects of Cs.
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Materials and methods
Cell culture
HeLa and HeLa.S-Fucci cells were routinely cultivated in Dulbecco's modified Eagle's medium (DMEM; Wako Pure Chemical Industries, Ltd., Osaka, Japan) supplemented with 10% FBS at 37°C in a 5% CO 2 humidified incubator. A subline of the HeLa cell line expressing Fucci, a cell cycle marker, HeLa.S-Fucci (RCB2812), was provided by the RIKEN BRC through the National Bio-Resource Project of the MEXT, Japan [11] . For all experiments, HeLa and HeLa.S-Fucci cells were plated in DMEM, incubated overnight, and incubated in DMEM supplemented with specific concentrations of Cs or inhibitors.
Cell counting and viability assay
Cells cultured in 96-well culture plates were assessed using the Cell Counting Kit (Dojindo Laboratories, Kumamoto, Japan), and lactate dehydrogenase (LDH) activity was measured using a Cytotoxicity Detection Kit (LDH) (Roche Diagnostics K.K., Tokyo, Japan, https://pim-eservices. roche.com/LifeScience/Document/dc220baa-d3ed-e311-98a1-00215a9b0ba8), according to the manufacturers' instructions. Cell viability was also evaluated using the trypan blue dye exclusion assay.
Cell cycle analysis
The two cell cycle Fucci probes, mKO2-hCdt1(30/120) and mAG-hGem(1/110), are often called mKO2-Cdt1 and mAG-Geminin, respectively. The red fluorescence observed upon expression of mKO2-Cdt1 indicates late G 1 phase and the green fluorescence observed upon expression of mAG-Geminin indicates S/G 2 /M phases. HeLa.S-Fucci cells, which express the two Fucci probes, were used for the cell cycle analysis. Cells were cultivated for 2 days in DMEM at 37°C in 5% CO 2 with 10 mM CsCl or 0.1 mM quinidine. The cell cycle distribution was analyzed by measuring the two Fucci probes using a BD FACSCalibur TM (Nippon Becton Dickinson, Tokyo, Japan) equipped with a 15-mW air-cooled 488-nm argonion laser. At least 10 000 events were collected, and debris was excluded by gating based on a plot of the forward versus side scatter. We used the gating to plot mAG-Geminin versus mKO2-Cdt1 and identify the cell cycle phase. The data were analyzed with CellQuest Pro software (Nippon Becton Dickinson). The cell division cycle was measured by time-lapse microscopic observations. The microscopic photographs were captured every 10 min using the BZ-9000 fluorescent microscope system (Keyence, Osaka, Japan). One cell cycle period was defined as the period between the visualization of red fluorescence in a mother cell and daughter cell. 
Intracellular pH
Intracellular Cs concentration
Intracellular Cs concentrations were measured with a capillary electrophoresis (CE) analysis using a P/ACE MDQ system (Beckman Coulter K.K., Tokyo, Japan). The capillary column was prepared and CE conditions followed previously reported methods [13, 14] . Fused silica capillaries (50 lm inner diameter, 375 lm outer diameter, length 30 cm) were obtained from GL Sciences (GL Sciences Inc., Tokyo, Japan). The culture media were aspirated from 80-90% confluent cultures, and the cultured cells were washed with a 0.33 M mannitol solution three times. The cells were then suspended in an appropriate volume of the 0.33 M mannitol solution. The cell suspension was stored at À20°C until analysis. The frozen cell suspension was heated at 98°C for 5 min and then centrifuged at 15 000 9 g for 5 min. A background electrolyte consisting of 5 mM imidazole and 2 mM 18-crown-6 was used to determine the cation concentrations in the supernatant, and the pH was adjusted to 4.5 with H 2 SO 4 . The absorbance was measured at 214 nm, and the background was subtracted. The cell volumes were calculated by a diameter of cell. The diameters of suspended, detached cells (n = 400) were measured from the microscopic images. The average cell volume was 1.26 AE 0.67 pL. Intracellular concentrations of K, Na, and Cs were calculated by the suspension of cell number and the average cell volume.
Pyruvate kinase activity assay
Pyruvate kinase activity was measured using an LDH assay at 25°C. The standard assay cuvette contained 10 mM Tris-HCl (pH 7.4), 100 mM KCl, 10 
Results
Cs suppresses proliferation in a dose-dependent manner
HeLa cell proliferation was assessed using the Cell Counting Kit, and Cs suppressed proliferation in a dose-dependent manner (Fig. 1A ). For the CsCl treatments, NaCl was added to DMEM to maintain a total CsCl and NaCl concentration of 30 mM and maintain the osmotic pressure. The data were fitted using the equation:
where Y is the relative proliferation (%), A is the maximum value, CsCl is the CsCl concentration in DMEM (mM), EC 50 is the effective concentration (mM), and h is a coefficient. The effective concentration of Cs + was 10.9 AE 0.9 mM, which is higher than effective concentration observed in C6 glioma cells, 4.75 mM [15] . Although cell proliferation was suppressed by~54% in response to 10 mM Cs, the cell viability was 80.7 AE 2.9% (Fig. 1B) .
Extracellular LDH activity was measured to determine whether Cs induced plasma membrane damage (Fig. 1C) . The increase in the extracellular LDH activity depends on plasma membrane leakage; therefore, LDH activity indicates plasma membrane integrity. The LDH activity in the extracellular media was not increased following the addition of 0.3-30 mM NaCl to DMEM as a control. The extracellular LDH activity and concomitant plasma membrane damage were not affected by the addition of NaCl to DMEM in doses up to 30 mM. Compared with NaCl, the addition of 0.3-10 mM CsCl to DMEM did not increase the LDH activity. In the LDH assay, the EC 50 was 44 AE 13 mM for Cs. Although the cells cultured in DMEM with 30 mM Na + did not exhibit increased LDH activity, the same concentration of Cs + seemed increase the LDH activity. Cs + concentrations < 10 mM Cs + in DMEM do not induce plasma membrane damage and do not critically decrease cell viability. Regarding the other alkaline metal salts, including LiCl, NaCl, KCl, and RbCl, a dose of 10 mM of each salt did not suppress HeLa cell growth (Fig. 2 ). The addition of LiCl, NaCl, KCl, or RbCl to DMEM at concentrations of up to 30 mM did not influence HeLa cell growth (data not shown). We determine whether this growth suppression effect of Cs was reversible (Fig. 3) . HeLa cells were cultured in the presence or (details in the text). The means of three independent measurements were calculated, and error bars indicate the standard deviations (n = 3). (B) Cell viability was estimated using the trypan blue dye exclusion assay. Significant differences between the control and CsCltreated cells are indicated by asterisks (P < 0.05 using Student's t-test). (C) LDH assay. The data represent the means of triplicate measurements and error bars indicate the standard deviations (n = 3).
absence of 10 mM CsCl for 3 days. The CsCl-treated cells grew more slowly than the controls. The apparent doubling time (T) was fitted using the equation: N = N 0 9 2 (t/T) , where t is the incubation time (h), N is the cell number, and N 0 is the initial cell number. The apparent doubling time of the 10 mM CsCl-treated cells was 74 AE 25 h, which was~2.2-fold slower than the control cells (33.2 AE 1.2 h). After 3 days, the media were removed and the cells were washed with fresh media without CsCl. The removal of Cs allowed cell growth to recover, and the apparent doubling time was the same as the control cells (31.5 AE 1.3 h; Fig. 3 ). Thus, Cs reversibly regulates cell proliferation.
Effect of Cs on the cell cycle
Potassium channel antagonists inhibit the proliferation of many types of cells, and the activation of K channels might be required for proliferation [16, 17] . The addition of Cs to the culture media decreased cell proliferation; however, the proliferation arrest did not seem to be severe. We used the Fucci-probe system (Fig. 4) and propidium iodide staining (Fig. S2, see also Data S1) to analyze the effect of Cs on the cell cycle. The probes mAG-Geminin (green fluorescent) and mKO2-Cdt1 (red fluorescent) represent S/G 2 /M phase and late G 1 phase, respectively. As previously reported [16, 17] , the cell cycle arrested in G 1 phase when quinidine was added to the culture media ( Fig. 4C and Fig. S2B ). In the Fucci-probe system analysis, Cs did not strongly arrest the cells in G 1 phase compared with quinidine. Propidium iodide staining analysis also showed the same phenomena. Although the Fucci-probe system analysis revealed that the cell phase ratio was not strongly affected by Cs (Fig. 4B) , the S phase ratio of CsCl-treated cells in the propidium iodide staining analysis seemed to be higher than control (Fig. S2B) . To evaluate the difference between the Fucci-probe system analysis and the propidium iodide staining analysis, we attempted to measure the cell division cycle using microscopic observations (Table 1) . One cell cycle period was Fig. 2 . Effects of alkali metals on cell proliferation. HeLa cells were cultured in DMEM with 10% FBS at 37°C with 5% CO 2 (control). HeLa cells were cultured in this media supplemented with 10 mM chloride salts of alkali metals (Li, Na, K, Rb, and Cs) to assess the effects of alkali metals on cell proliferation. The means of three independent measurements were calculated, and error bars indicate the standard deviations. The data are presented as the means AE SD (n = 3).
defined as the period between the visualization of red fluorescence (G 0 /G 1 phase) in the nucleus of the mother cell and the nucleus of the daughter cell. The red fluorescence was observed in G 0 /G 1 phase. S/G 2 phase was defined as the period between the initial observation of yellow fluorescence in the nucleus, which was produced by the merger of red (G 1 phase) and green (S phase) fluorescence, and whole cell green fluorescence. Whole cell green fluorescence represented M phase. The cell phases of the control and 3 mM CsCl-treated cells were the same, and the 10 mM CsCltreated cells extended the amount of time that cells spent in all phases of the cell cycle. The total cell division cycle of Cs-treated cells was~1.6-fold longer than the control cells.
Cs entered the cell and interrupted intracellular metabolism
The intracellular cation concentrations in HeLa cells were analyzed to clarify whether Cs + can be transported into the cells. Cytosolic extracts were prepared from cells cultured with or without 10 mM Cs + . Na + and K + were detected in the cytosolic extracts from both the control and Cs + -treated cells, but Cs + was only detected in the cytosolic extracts of the Cs + -treated cells (Fig. 5A) . The cell volume was first measured to estimate the intracellular ion concentrations. The diameters of suspended, detached cells were measured from the microscopic images and the cell volumes were calculated. The average cell volume was 1.26 pL. The intracellular Na + and K + concentrations in the control cells were 28.5 AE 13.0 and 107.6 AE 0.5 mM, respectively, but Cs + was not detected in the control cells. The intracellular Na + , K + , and Cs + concentrations in the CsCl-treated cells were 25.9 AE 7.6, 78.0 AE 6.4, and 22.1 AE 0.9 mM, respectively (Fig. 5B) . The intracellular Na + concentrations were the same in the Cs-treated and control cells, but the intracellular K + concentrations were decreased and the Cs + concentrations were increased in the Cs-treated cells compared to the control cells. However, the sum of the intracellular K + and Cs + concentrations in the Cstreated cells was similar to the intracellular K + concentrations in the control cells. The intracellular Cs concentration was higher than the extracellular Cs concentration; therefore, Cs was incorporated in the intracellular space.
Pyruvate kinase, which catalyzes the final step of glycolysis in the cytosol, produces pyruvate and ATP from the substrates phosphoenolpyruvate and ADP. In this catalysis step, pyruvate kinase requires K + as a cofactor [18] pyruvate kinase activity was decreased in a manner dependent on the intracellular Cs + content.
Intracellular pH determination
The decrease in pyruvate kinase activity was postulated to cause a decrease in intracellular metabolism, which induced a reduction in the acidic metabolite levels. The intracellular pH was measured in cells cultured with alkali metals and some K + channel blockers using flow cytometry (Fig. 7) . A representative histogram of the BCECF fluorescence (FL1-H) data obtained from the flow cytometry measurements is shown in Fig. 7A . The geometric mean BCECF fluorescence depends on the intracellular pH of the cells. The intracellular pH was measured in cells cultured with alkali metals and some K + channel blockers using a standard pH curve, which was generated at each measurement. The intracellular pH of the control cells was 6.94 AE 0. 
Discussion
Cesium and K are alkaline metals. The Cs concentration in the Earth's crust is~3 mgÁkg À1 [19] . People usually ingest stable Cs through crops, which take up Cs from arable land. Concentrations of Cs in the soil and in potatoes from fields in Japan were 1-11 mgÁkg
À1
and 0.004-0.13 mgÁkg
dry weight, respectively, in 1991-1994 [20] , and those in paddy soil and polished rice were 1.2-53 mgÁkg À1 and 0.0005-0.0065 mgÁkg À1 dry weight, respectively, in 1996-1997 [21] . Cs ingested via food is assumed to be distributed to the tissues throughout the body in its ionic state through pathways similar to those for distribution of K + . After intraperitoneal administration of 134 Cs to rats as a chloride salt, it was found to be distributed in the intestinal tract, muscle, liver, lungs, heart, kidneys, testes, stomach, and spleen [22] . Radioactive Cs was also released into the environment around the nuclear power plants in Fukushima Prefecture after the Fukushima nuclear accident on March 11, 2011. The effect of this Cs, which was consumed via food and entered the human body, has not yet been The data are presented as the means AE SD (n = 3). Significant differences between the control and treated cells are indicated by asterisks (P < 0.01 using Student's t-test). extracts (Fig. 5 ) and the concentration was higher than its extracellular concentration. Thus, HeLa cells possess at least one Cs + uptake pathway. The addition of Cs + to the culture medium at concentrations up to 10 mM was less toxic toward the cytoplasmic membrane of HeLa cells, as assessed by the trypan blue dye exclusion and LDH assays (Fig. 1) . This result suggests that the addition of Cs + to the medium did not disrupt the cytoplasmic membrane or cause leakage of the intracellular contents, including LDH. The proliferation of the Cs-treated cells was slow (Fig. 2) , and removal of Cs + from the medium restored their proliferation rate (Fig. 3) . HeLa cell growth was recovered by excluding Cs + from the extracellular medium. Thus, HeLa cell proliferation was not disrupted by Cs + . HeLa cell proliferation was inhibited by the addition of 10 mM Cs to the culture medium, whereas this effect was reversed by removing Cs from the culture medium (Fig. 3) . Therefore, the inhibitory effect of Cs on cell proliferation was reversible. These results were in good agreement with the reversible inhibition of cell proliferation by the K + channel blockers glibenclamide and quinidine in MCF-7 human breast cancer tumor cells [17] . However, K + channel blockers did not always inhibit cell growth. Charybdotoxin, iberiotoxin, margatoxin, and apamin did not inhibit the growth of human MCF-7 cells, but linogliride, 4-AP, and TEA suppressed their proliferation. However, these drugs did not show reversible effects. Glibenclamide and quinidine, which inhibited ATP-sensitive K + channels, induced cell cycle arrest during the G 1 phase, thereby preventing cell proliferation [16, 17] . Furthermore, Weigher et al. [15] reported that the growth of mouse C6-glioma cells was also inhibited by quinidine and Cs. The half-effective concentration required to induce cytotoxicity was 112 lM for quinidine and 4.75 mM for Cs, as estimated using the LDH assay. Therefore, Cs might act as an ATPsensitive K + channel blocker, similarly to glibenclamide and quinidine as observed in previous studies. Although excessive drug use inhibits cell proliferation, the reversible inhibition of cell proliferation by Cs + is assumed to be physiologically mild.
We analyzed the cell division cycle by microscopic observations using Fucci indicator probes. Cells treated with Cs concentrations of up to 3 mM Cs did not display any difference in the cell division cycle; however, 10 mM Cs treatment extended the amount of time that cells spent in all phases of the cell cycle (Table 1) . Although the K + channel blocker quinidine induced cell cycle arrest during the G 1 phase, Cs + did not show the same effect (Fig. 4) . Although the Fucciprobe system analysis could not clearly separate the S phase from the G 1 and G 2 phases by flow cytometry, the other propidium iodide staining analysis revealed the S phase. This latter analysis indicated that 10 mM CsCl treatment increased the proportion of cells in the S phase and decreased that in the G 2 /M phase compared with those in the control (Fig. S2) . The time that Cs-treated cells spent in each phase of the cell cycle was longer than that spent by the control cells (Table 1) . During 2 days of cultivation, the control cells were thought to divide approximately twice; however, the Cs-treated cells were thought to divide once and then proceed to the second cell division (Table 1) . Prior to the propidium iodide staining analysis, the cells were synchronized at the M phase by nocodazole in normal DMEM; subsequently, the cells were transferred to fresh DMEM in the presence or absence of 10 mM CsCl. Both the control and Cs-treated cells underwent cell division. However, CsCl treatment slowed down the progression through the cell cycle. The effect of Cs + on proliferation was not to interrupt cell division but to slow down the cell cycle and thus extended the cell division time. Further studies are required to understand the relationship between Cs + and the cell cycle.
The proposed mechanisms by which Cs + suppresses cell proliferation are described below. Cs + was transferred to the intracellular space through the cell membrane via a K + transporter(s); thus, Cs + influx increased and K + influx decreased (Fig. 5) . The cytoplasmic space had lower K + and higher Cs + concentrations than the general cytosolic cation composition. In the cytosolic environment, an enzyme associated with glycolysis, pyruvate kinase, which requires K + as a cofactor for catalysis, did not show high activity (Fig. 6, Fig. S1 ). A decrease in glycolysis might inhibit pyruvate kinase, and, subsequently, alter intracellular metabolite production, which probably decreased the levels of the metabolite. The metabolites are generally acidified compounds; therefore, the decrease in acidic metabolite production induced by the Cs treatment shifted the intracellular pH to an alkaline level (Fig. 7) . Alkalization of the intracellular environment also suppressed cell proliferation. Subsequently, cell proliferation was suppressed by Cs + intake. Further experiments, such as the detection of intracellular metabolites, are necessary to confirm this hypothesis. Moreover, in future studies, we must investigate other cell lines to determine whether these phenomena are specific to HeLa cells.
From a physiological perspective, the types of ion channel or transporter involved in transporting Cs through cell membranes must be identified. For people living in Fukushima, Japan, after the Fukushima nuclear disaster, information on the effects of Cs + on the human body is particularly important. Studying the dynamics of Cs + at the cellular level is thus an important task for scientists living in Fukushima. We speculated that HeLa cells also possess at least one Cs + -export pathway. We will investigate this pathway (s) involved in transporting Cs across the cell membrane in future studies.
Intraperitoneal administration of different doses of CsCl in mice resulted in the rapid transfer of Cs + from the blood to the tissue compartments. Mice that were intraperitoneally injected with CsCl for 14 consecutive days prior to sarcoma implantation exhibited reduced tumor-induced mortality compared with controls [23] . Intraperitoneal administration of different doses of CsCl in mice was associated with the rapid transfer of Cs + from the blood to the tissue compartments. Mice that were intraperitoneally injected with CsCl for 14 consecutive days prior to sarcoma implantation exhibited reduced tumor-induced mortality compared with the controls [23] . A group of mice were administered 28 once-daily intraperitoneal injections of CsCl, at 5 mEqÁkg À1 Áday À1 . Twenty-eight days after the final injection, the mice tissues were shown to have accumulated Cs during this period, in the following order: skeletal muscle > ileum > brain > liver > lung > blood. The Cs content was 11.5-144 mEqÁkg À1 wet tissue in the skeletal muscle and 10-20 mEqÁkg À1 in the blood [24] . These levels were in good agreement with the distribution of Cs-134 in the adult rat after intraperiotoneal administration [22] . From these reports, it can be concluded that Cs could accumulate in some tissues to a level of~10 mM. If the distribution of Cs concentration in humans is the same as that in mice and rats, oral intake of 6 g CsClÁday À1 [1, 6, 7] in adult humans would lead to concentrations of over 10 mEqÁkg À1 of CsCl in the skeletal muscle, ileum, liver, and lung. Incorporation of Cs in the tissues was expected to decrease tumor progression. In this study, Cs + suppressed cell proliferation, and pyruvate kinase activity in the glycolysis pathway was involved in suppressing cell growth. These results are in good agreement with the Warburg effect on tumor cell metabolism. If we control Cs + uptake by the cells, Cs + would play a key role in suppressing tumor progression in a clinical context. In conclusion, the results of our investigation of the effects of Cs + on cultured human cells suggested that Cs + suppressed cell proliferation without inducing severe damage in the cells. These findings support the idea of using Cs to inhibit tumor growth without damaging the normal tissue. Our ultimate aim is to identify the Cs ion channels or transporters.
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